Published in PLoS One on March 02, 2012
Impact of L-FABP and glucose on polyunsaturated fatty acid induction of PPARα-regulated β-oxidative enzymes. Am J Physiol Gastrointest Liver Physiol (2012) 0.90
Structural and functional interaction of fatty acids with human liver fatty acid-binding protein (L-FABP) T94A variant. FEBS J (2014) 0.89
A54T polymorphism in the fatty acid binding protein 2 studies in a Saudi population with type 2 diabetes mellitus. Lipids Health Dis (2014) 0.86
Loss of intracellular lipid binding proteins differentially impacts saturated fatty acid uptake and nuclear targeting in mouse hepatocytes. Am J Physiol Gastrointest Liver Physiol (2012) 0.85
The human liver fatty acid binding protein T94A variant alters the structure, stability, and interaction with fibrates. Biochemistry (2013) 0.85
Plasma levels of FABP4, but not FABP3, are associated with increased risk of diabetes. Lipids (2012) 0.81
Microarray analysis of rat pancreas reveals altered expression of Alox15 and regenerating islet-derived genes in response to iron deficiency and overload. PLoS One (2014) 0.81
Loss of L-FABP, SCP-2/SCP-x, or both induces hepatic lipid accumulation in female mice. Arch Biochem Biophys (2015) 0.80
Recent insights into the biological functions of liver fatty acid binding protein 1. J Lipid Res (2015) 0.79
Common genetic variants of surfactant protein-D (SP-D) are associated with type 2 diabetes. PLoS One (2013) 0.79
Fatty Acid Binding Protein-1 (FABP1) and the Human FABP1 T94A Variant: Roles in the Endocannabinoid System and Dyslipidemias. Lipids (2016) 0.78
Female Mice are Resistant to Fabp1 Gene Ablation-Induced Alterations in Brain Endocannabinoid Levels. Lipids (2016) 0.76
Impact of dietary phytol on lipid metabolism in SCP2/SCPX/L-FABP null mice. Biochim Biophys Acta (2016) 0.75
Association of single-nucleotide polymorphisms rs2197076 and rs2241883 of FABP1 gene with polycystic ovary syndrome. J Assist Reprod Genet (2015) 0.75
Variation in genes related to hepatic lipid metabolism and changes in waist circumference and body weight. Genes Nutr (2014) 0.75
Interaction between genes and macronutrient intake on the risk of developing type 2 diabetes: systematic review and findings from European Prospective Investigation into Cancer (EPIC)-InterAct. Am J Clin Nutr (2017) 0.75
Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (2004) 125.23
Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol (1995) 30.55
Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation (2004) 20.67
Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care (2003) 20.07
Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol (2002) 6.09
Sample size requirements for matched case-control studies of gene-environment interaction. Stat Med (2002) 5.00
Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science (1996) 4.61
The SNPlex genotyping system: a flexible and scalable platform for SNP genotyping. J Biomol Tech (2005) 2.64
New insights into the structure and function of fatty acid-binding proteins. Cell Mol Life Sci (2002) 2.18
Health-related quality of life of subjects with known and unknown hypertension: results from the population-based Hortega study. J Hypertens (2003) 2.12
[Prevalence of the metabolic syndrome (ATP-III criteria). Population-based study of rural and urban areas in the Spanish province of Segovia]. Med Clin (Barc) (2005) 1.69
The crystal structure of the liver fatty acid-binding protein. A complex with two bound oleates. J Biol Chem (1997) 1.63
Effect of the interaction between the fatty acid binding protein 2 gene Ala54Thr polymorphism and dietary fatty acids on peripheral insulin sensitivity: a cross-sectional study. Am J Clin Nutr (2007) 1.51
Differential expression of lumican and fatty acid binding protein-1: new insights into the histologic spectrum of nonalcoholic fatty liver disease. Hepatology (2009) 1.21
Genetic variation in fatty acid-binding protein-4 and peroxisome proliferator-activated receptor gamma interactively influence insulin sensitivity and body composition in males. Metabolism (2004) 1.07
Effect of liver fatty acid binding protein (FABP) T94A missense mutation on plasma lipoprotein responsiveness to treatment with fenofibrate. J Hum Genet (2004) 1.00
Thr54 allele carriers of the Ala54Thr variant of FABP2 gene have associations with metabolic syndrome and hypertriglyceridemia in urban South Indians. Metabolism (2006) 0.99
Plasma concentrations of apolipoprotein B are modulated by a gene--diet interaction effect between the LFABP T94A polymorphism and dietary fat intake in French-Canadian men. Mol Genet Metab (2004) 0.93
Polymorphisms in fatty acid-binding protein-3 (FABP3) - putative association with type 2 diabetes mellitus. Hum Mutat (2003) 0.90
Renin polymorphisms and haplotypes are associated with blood pressure levels and hypertension risk in postmenopausal women. J Hypertens (2008) 0.86
Association of the intestinal fatty acid-binding protein Ala54Thr polymorphism and abdominal adipose tissue in African-American and Caucasian women. J Clin Endocrinol Metab (2004) 0.86
Genetics of insulin resistance. Curr Diab Rep (2002) 0.86
Identification of a functional polymorphism at the adipose fatty acid binding protein gene (FABP4) and demonstration of its association with cardiovascular disease: a path to follow. Nutr Rev (2007) 0.85
Thr54 allele of the FABP2 gene affects resting metabolic rate and visceral obesity. Diabetes Res Clin Pract (2005) 0.84
[Cardiovascular risk factors in diabetic patients. Cross-sectional study in general population: Hortega study]. An Med Interna (2003) 0.83
Identification of a 2244 base pair interstitial deletion within the human ESR1 gene in the Spanish population. J Med Genet (2008) 0.78
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43
European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens (2003) 5.94
Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med (2002) 5.72
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens (2009) 4.87
European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens (2013) 4.28
Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways. Diabetes (2010) 4.07
Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients. Hypertension (2009) 3.93
European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens (2008) 3.32
Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21
Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens (2005) 3.15
Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens (2009) 3.13
Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study. J Hypertens (2009) 2.68
2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension. Blood Press (2013) 2.62
Effect of iodine prophylaxis during pregnancy on neurocognitive development of children during the first two years of life. J Clin Endocrinol Metab (2009) 2.42
Added impact of obesity and insulin resistance in nocturnal blood pressure elevation in children and adolescents. Hypertension (2008) 2.31
ESH position paper: renal denervation - an interventional therapy of resistant hypertension. J Hypertens (2012) 2.24
Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes. Diabetes (2011) 2.21
[Organization of healthcare for transsexual persons in the Spanish national health system]. Gac Sanit (2012) 2.05
Ambulatory blood pressure values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET). Hypertension (2012) 2.02
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press (2009) 1.98
Carotid-femoral pulse wave velocity assessment by two different methods: implications for risk assessment. J Hypertens (2015) 1.98
Antihypertensive activity of angiotensin II AT1 receptor antagonists: a systematic review of studies with 24 h ambulatory blood pressure monitoring. J Hypertens (2007) 1.86
Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET). Circulation (2011) 1.77
Microvascular brain damage with aging and hypertension: pathophysiological consideration and clinical implications. J Hypertens (2011) 1.76
A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One (2012) 1.72
Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. BMC Med (2013) 1.71
Blood pressure and obesity exert independent influences on pulse wave velocity in youth. Hypertension (2012) 1.70
[Prevalence of the metabolic syndrome (ATP-III criteria). Population-based study of rural and urban areas in the Spanish province of Segovia]. Med Clin (Barc) (2005) 1.69
Influence of concurrent obesity and low birth weight on blood pressure phenotype in youth. Hypertension (2009) 1.64
Prevalence, persistence, and clinical significance of masked hypertension in youth. Hypertension (2005) 1.61
[Validation of the FINDRISC (FINnish Diabetes RIsk SCore) for prediction of the risk of type 2 diabetes in a population of southern Spain. Pizarra Study]. Med Clin (Barc) (2011) 1.59
European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens (2014) 1.58
Serum phospholipid fatty acid profile and dietary intake in an adult Mediterranean population with cystic fibrosis. Br J Nutr (2006) 1.55
Response to a urate-lowering diet according to polymorphisms in the apolipoprotein AI-CIII-AIV cluster. J Rheumatol (2005) 1.53
Relationship between bone mineral density and angiotensin converting enzyme polymorphism in hypertensive postmenopausal women. Am J Hypertens (2003) 1.52
Associations of birth weight and postnatal weight gain with cardiometabolic risk parameters at 5 years of age. Hypertension (2014) 1.52
Effect of the interaction between the fatty acid binding protein 2 gene Ala54Thr polymorphism and dietary fatty acids on peripheral insulin sensitivity: a cross-sectional study. Am J Clin Nutr (2007) 1.51
Differential subcellular distribution of glucose transporters GLUT1-6 and GLUT9 in human cancer: ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues. J Cell Physiol (2006) 1.51
Association of central and peripheral pulse pressure with intermediate cardiovascular phenotypes. J Hypertens (2012) 1.49
Markers for the validation of reported dietary intake in adults with cystic fibrosis. J Am Diet Assoc (2009) 1.47
Analysis of sequence variations in the LDL receptor gene in Spain: general gene screening or search for specific alterations? Clin Chem (2006) 1.46
[Physical activity and cardiovascular and metabolic risk factors in general population]. Med Clin (Barc) (2003) 1.44
2016 European Guidelines on cardiovascular disease prevention in clinical practice. Rev Esp Cardiol (Engl Ed) (2016) 1.42
[8-oxo-7,8-dihydro-2'-deoxyguanosine as a marker of DNA oxidative stress in individuals with combined familiar hyperlipidemia]. Med Clin (Barc) (2008) 1.42
Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study. J Clin Endocrinol Metab (2013) 1.41
Regression of left ventricular hypertrophy and microalbuminuria changes during antihypertensive treatment. J Hypertens (2013) 1.39
[Renal function as a prognostic marker of mortality in heart failure]. Med Clin (Barc) (2009) 1.38
[Glycosylated hemoglobin as a hyperuricemia risk marker in general population]. Med Clin (Barc) (2011) 1.38
Road extraction from aerial images using a region competition algorithm. IEEE Trans Image Process (2006) 1.38
Genetic structure of the Spanish population. BMC Genomics (2010) 1.34
The FTO obesity gene. Genotyping and gene expression analysis in morbidly obese patients. Obes Surg (2008) 1.31
Serum circulating microRNA profiling for identification of potential type 2 diabetes and obesity biomarkers. PLoS One (2013) 1.24
[Evolution of prevalence of type 2 diabetes in adult Spanish population]. Med Clin (Barc) (2007) 1.18
Blood pressure in chronic kidney disease stage 5D-report from a Kidney Disease: Improving Global Outcomes controversies conference. Kidney Int (2009) 1.16
Extractable soil heavy metals following the cessation of biosolids application to agricultural soil. Environ Pollut (2002) 1.16
Worldwide occurrence of feline hemoplasma infections in wild felid species. J Clin Microbiol (2007) 1.13
Feline leukemia virus and other pathogens as important threats to the survival of the critically endangered Iberian lynx (Lynx pardinus). PLoS One (2009) 1.12
Lipodystrophy and metabolic syndrome in HIV-infected patients treated with antiretroviral therapy. Metabolism (2006) 1.10
Retroperitoneal mucinous cystadenoma. Arch Gynecol Obstet (2003) 1.05
Stearoyl-CoA desaturase-1 is associated with insulin resistance in morbidly obese subjects. Mol Med (2010) 1.05
An SNP in the adiponectin gene is associated with decreased serum adiponectin levels and risk for impaired glucose tolerance. Obes Res (2005) 1.02
Geographic variations of the International Diabetes Federation and the National Cholesterol Education Program-Adult Treatment Panel III definitions of the metabolic syndrome in nondiabetic subjects. Diabetes Care (2006) 1.02
Perioperative intravenous iron, with or without erythropoietin, plus restrictive transfusion protocol reduce the need for allogeneic blood after knee replacement surgery. Transfusion (2006) 1.01
Depression and anxiety symptoms in bronchiectasis: associations with health-related quality of life. Qual Life Res (2012) 1.00
Which obesity index best explains prevalence differences in type 2 diabetes mellitus? Obesity (Silver Spring) (2007) 1.00
Visual tracking of plant virus infection and movement using a reporter MYB transcription factor that activates anthocyanin biosynthesis. Plant Physiol (2012) 0.99
Intelligence quotient and iodine intake: a cross-sectional study in children. J Clin Endocrinol Metab (2004) 0.98
The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease. Genome Med (2011) 0.98
Central adiposity determines prevalence differences of the metabolic syndrome. Obes Res (2003) 0.98
Preoperative haematinics and transfusion protocol reduce the need for transfusion after total knee replacement. Int J Surg (2006) 0.97
Lipid accumulation product: a powerful marker of metabolic syndrome in healthy population. Eur J Endocrinol (2011) 0.97
Two Triatoma dimidiata clades (Chagas disease vector) associated with different habitats in southern Mexico and Central America. Am J Trop Med Hyg (2008) 0.96
The association between leptin and left ventricular hypertrophy: a population-based cross-sectional study. J Hypertens (2003) 0.96
Pro12Ala polymorphism of the PPARG2 gene is associated with type 2 diabetes mellitus and peripheral insulin sensitivity in a population with a high intake of oleic acid. J Nutr (2006) 0.96
Ability of lipid accumulation product to identify metabolic syndrome in healthy men from Buenos Aires. Diabetes Care (2009) 0.95
Glial glucokinase expression in adult and post-natal development of the hypothalamic region. ASN Neuro (2010) 0.94
Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study. J Hypertens (2013) 0.94
Variant rs9939609 in the FTO gene is associated with obesity in an adult population from Spain. Clin Endocrinol (Oxf) (2008) 0.94
Importance of canine distemper virus (CDV) infection in free-ranging Iberian lynxes (Lynx pardinus). Vet Microbiol (2010) 0.94
Type 2 diabetes mellitus and other cardiovascular risk factors are no more common during menopause: longitudinal study. Menopause (2009) 0.93
The impact of the degree of obesity on the discrepancies between office and ambulatory blood pressure values in youth. J Hypertens (2006) 0.93
Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group 'Hypertension Arrhythmias and Thrombosis' of the European Society of Hypertension. J Hypertens (2012) 0.93
Metabolomic profiling in blood from umbilical cords of low birth weight newborns. J Transl Med (2012) 0.93